elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36445523-E30AD193-E22B-423F-8112-248319D19599
Q36445523-E30AD193-E22B-423F-8112-248319D19599
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36445523-E30AD193-E22B-423F-8112-248319D19599
Targeting EZH2 and PRC2 dependence as novel anticancer therapy.
P2860
Q36445523-E30AD193-E22B-423F-8112-248319D19599
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36445523-E30AD193-E22B-423F-8112-248319D19599
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
21e7c4c2012fd6d2151573de08cb4df977d48aee
P2860
WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation